fucose and HIV Coinfection

fucose has been researched along with HIV Coinfection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Anderluh, M; Fieschi, F; Hajšek, D; Luzar, J; Obermajer, N; Petit-Haertlein, I; Švajger, U; Tomašić, T1
Abdel-Mohsen, M; George, AF; Giron, L; Ma, T; McGregor, M; Roan, NR; Xie, G1
Abdel-Mohsen, M; Adeniji, OS; Battivelli, E; Betts, MR; Colomb, F; Dweep, H; Giron, LB; Kossenkov, AV; Kuri-Cervantes, L; Ma, T; Palmer, CS; Roan, NR; Tateno, H; Verdin, E1
Alter, G; Joosten, SA; Ottenhoff, THM1
Andreini, M; Belvisi, L; Bernardi, A; Chabrol, E; Doknic, D; Doro, F; Duan, J; Fieschi, F; Moroni, E; Reina, JJ; Rojo, J; Sutkeviciute, I; Thepaut, M; Weiser, J1
Bélec, L; Magri, G; Nasreddine, N; Réquena, M; Saïdi, H1

Reviews

1 review(s) available for fucose and HIV Coinfection

ArticleYear
Antibody glycosylation in inflammation, disease and vaccination.
    Seminars in immunology, 2018, Volume: 39

    Topics: Aging; Antibodies; Antigens; Carbohydrate Sequence; Fucose; Galactose; Glycosylation; HIV Infections; Humans; Immunoglobulin G; Inflammation; Influenza, Human; Protein Processing, Post-Translational; Sialic Acids; Vaccination; Viral Vaccines

2018

Other Studies

5 other study(ies) available for fucose and HIV Coinfection

ArticleYear
Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    Topics: Binding Sites; Cell Adhesion Molecules; Dendritic Cells; HIV Envelope Protein gp120; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Lectins, C-Type; Mannose; Molecular Docking Simulation; Receptors, Cell Surface

2014
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV.
    eLife, 2022, 07-05, Volume: 11

    Topics: CD4-Positive T-Lymphocytes; Disease Susceptibility; Fucose; Glycomics; HIV Infections; HIV-1; Humans; N-Acetylneuraminic Acid; Polysaccharides

2022
Sialyl-Lewis
    Cell reports, 2020, 08-04, Volume: 32, Issue:5

    Topics: Antiretroviral Therapy, Highly Active; Carbohydrates; CD4-Positive T-Lymphocytes; Cell Line; Cell Membrane; Fucose; Glycomics; Glycosylation; HIV; HIV Infections; Humans; Immunologic Memory; Ligands; Lymphocyte Activation; Sialyl Lewis X Antigen; Transcription, Genetic

2020
Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.
    Organic & biomolecular chemistry, 2011, Aug-21, Volume: 9, Issue:16

    Topics: Anti-HIV Agents; Antigens, CD; Cell Adhesion Molecules; Fucose; HIV Infections; Humans; Lectins, C-Type; Mannose-Binding Lectins; Models, Molecular; Protein Binding; Receptors, Cell Surface

2011
R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
    Virology, 2007, Feb-05, Volume: 358, Issue:1

    Topics: Acetylglucosamine; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Chemokine CXCL1; Chemokines, CXC; Endocytosis; Endometrium; Epithelial Cells; Female; Fucose; Heparan Sulfate Proteoglycans; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Interleukin-1alpha; Interleukin-8; Lectins, C-Type; Mannose; Mannose Receptor; Mannose-Binding Lectins; Receptors, CCR5; Receptors, Cell Surface; Receptors, CXCR4; Tumor Necrosis Factor-alpha; Virulence; Virus Attachment

2007